Farther Finance Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.9K Buy
1,915
+538
+39% +$12.7K ﹤0.01% 3548
2026
Q2
$31.1K Sell
1,377
-530
-28% -$11.9K ﹤0.01% 3632
2026
Q1
$42.6K Buy
1,907
+927
+95% +$21.3K ﹤0.01% 3100
2025
Q4
$23.4K Buy
980
+181
+23% +$4.5K ﹤0.01% 3339
2025
Q3
$21K Buy
799
+31
+4% +$797 ﹤0.01% 3010
2025
Q2
$22K Buy
768
+3
+0.4% +$81 ﹤0.01% 2622
2025
Q1
$18.9K Sell
765
-9
-1% -$214 ﹤0.01% 2412
2024
Q4
$17.5K Buy
774
+294
+61% +$6.38K ﹤0.01% 2141
2024
Q3
$10.2K Buy
480
+224
+88% +$4.41K ﹤0.01% 2358
2024
Q2
$4.91K Buy
256
+5
+2% +$102 ﹤0.01% 2408
2024
Q1
$4.79K Sell
251
-36
-13% -$714 ﹤0.01% 2085
2023
Q4
$5.98K Buy
287
+117
+69% +$2.25K ﹤0.01% 1871
2023
Q3
$3.66K Buy
170
+166
+4,150% +$4.03K ﹤0.01% 1628
2023
Q2
$96 Hold
4
– – ﹤0.01% 2428
2023
Q1
$85 Hold
4
– – ﹤0.01% 2292
2022
Q4
$65 Buy
+4
New +$59 ﹤0.01% 2149

Other funds holding FMS

Farther Finance Advisors's FMS Position: Q3 2026 in Review

Farther Finance Advisors increased its Fresenius Medical Care (FMS) stake by 39% in Q3 2026, buying an estimated $12.7K and bringing the position to 1,915 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3548.

Farther Finance Advisors first reported a position in FMS in Q4 2022 and has held it in 16 quarters since. 12 funds tracked by Wall St. Rank hold FMS as of Q3 2026.

  • Farther Finance Advisors held 1,915 shares of Fresenius Medical Care worth $42.9K as of Q3 2026.
  • Farther Finance Advisors bought 538 Fresenius Medical Care shares in Q3 2026, an estimated $12.7K.
  • Fresenius Medical Care made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3548 holding.
  • Farther Finance Advisors first reported a position in Fresenius Medical Care in Q4 2022 and has held it in 16 quarters since.
  • 12 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.